|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 Maine AVE SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024-2002 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3151-12
|
||||||||
|
6. House ID# 304890000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Craig Obey |
Date | 7/18/2023 1:52:28 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies Appropriations Legislation
Fiscal Year 2024 Military Construction / Veterans Affairs Appropriations Legislation
H.R. 2811 - Limit, Save, Grow Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Craig |
Obey |
|
|
|
Mikael |
Troubh |
|
|
|
Tim |
Clement |
|
|
|
Daniel |
Stanford |
III |
|
|
Leslie |
Samuel |
|
|
|
Dana |
Doran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.Res. 436 - Expressing Support for the Designation of the Week of May 22 through26, 2023, as Educator Mental Health Awareness Week"
H.R. 498 - 988 Lifeline Cybersecurity Responsibility Act
H.R. 734 - Protection of Women and Girls in Sports Act of 2023
H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023
H.R. 1114 - Long COVID Recovery Now Act
H.R. 1201 - Increasing Behavioral Health Treatment Act
H.R. 1202 - REDI Act
H.R. 1359 / S. 644 - Modernization of Opioid Treatment Act
H.R. 1502 - Comprehensive Opioid Recovery Centers (CORC) Reauthorization Act
H.R. 1711 / S. 940 - Rural America Health Corps Act
H.R. 1839 - Combating Illicit Xylazine Act
H.R. 2389 - Resident Physician Shortage Reduction Act of 2023
H.R. 2400 / S. 1165 - Reentry Act of 2023
H.R. 2412 - Helping Kids Cope Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
H.R. 2713 - I CAN Act
H.R. 3073 / S. 1452 - Community Mental Wellness and Resilience Act of 2023
H.R. 3074 / S. 971 - Due Process Continuity of Care Act
H.R. 3150 / S. 983 - OPIOIDS Act
H.R. 3305 / S. 1606 - Black Maternal Health Momnibus Act
H.R. 3548 / S. 1700 Pursuing Equity in Mental Health Act
H.R. 3713 / S. 1884 Mental Health Services for Students Act
H.R.3570 - Comprehensive Response to Fentanyl-Related Substances and Fentanyl-laced Substances Act
H.R.3680 - Stop Mental Health Stigma in Our Communities Act
H.R. 3736 - Extending Access to Addiction Treatment Act
H.R. 3752 - Parity Enforcement Act of 2023
H.R. 3836 - Medicaid Primary Care Improvement Act
H.R. 3838 - Preventing Maternal Deaths Reauthorization Act
H.R. 3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs.
H.R. 3887 - Childrens Hospital GME Support Reauthorization Act of 2023
H.R. 3892 - Improving Mental Health and Drug Treatment Act
H.R. 4007 - HEAL Act
H.R. 4053 - Studying Suboxone Act
H.R. 4054 - Trauma Support and Mental Health in Schools Reauthorization Act
H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023
H.R. 4057 - Keeping Kids Safe Act
H.R. 4063 - FIND Fentanyl Act of 2023
H.R. 4079 - Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023
H.R. 4080 - Trauma-Informed Care Task Force Reauthorization Act of 2023
H.R. 4088 - CAREER Act
H.R. 4089 - Safer Response Act
H.R. 4091 - Combatting Substance Use Disorder Act
H.R. 4092 - Protecting Moms and Infants Reauthorization Act
H.R. 4093 - Remote Opioid Monitoring Act of 2023
H.R. 4095 - Save Children from Trauma Act
H.R. 4096 - A bill to amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries
H.R. 4097 - Mental Health Improvement Act
H.R. 4098 - Communities of Recovery Reauthorization Act
H.R. 4099 - RECONNECTS Act of 2023
H.R. 4100 - To amend the Public Health Service Act to reauthorize a monitoring and education program regarding infections associated with illicit drug use and other risk factors
H.R. 4101 - Road to Recovery Act
H.R. 4106 - To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips
H.R. 4189 / S. 2016 - CONNECT for Health Act
S. 462 - Mental Health Professionals Workforce Shortage Loan Repayment Act
S. 665 - Conrad State 30 and Physician Access Reauthorization Act
S. 669 - Increasing Mental Health Options Act of 2023
S. 923 - Better Mental Health Care for Americans Act
S.1378 - Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act
S. 1426 - RISE from Trauma Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Samuel |
|
|
|
Mikael |
Troubh |
|
|
|
Craig |
Obey |
|
|
|
Tim |
Clement |
|
|
|
Daniel |
Stanford |
III |
|
|
Dana |
Doran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 1639 / S. 853 - VA Zero Suicide Demonstration Project Act
H.R. 3011 - Servicemembers Mental Health Improvement Act
S. 10 - VA CAREERS Act
S. 1315 - Veterans HEALTH Act of 2023
S. 1545 - Veterans Health Care Freedom Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Stanford |
III |
|
|
Craig |
Obey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 3373 - Sailor Standard of Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Stanford |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |